BridgeMD
New treatment option for Prostate Hyperplasia
Official title Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate
ClinicalTrials.gov ID: NCT06649357
What this study is testing
- What it's testing
- Introduction: Multiple studies have demonstrated the superiority of HoLEP in aspects such as transfusión rates or postoperative stay. On the other hand, no differences have been observed in terms of functional outcomes between both techniques, and surgical times reported in different studies tend to be longer for HoLEP.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, men only
You may be able to join if
- Patients with maximum flow rate \ 15 ml/sec and urodynamic study showing high-flow obstruction defined as bladder outlet obstruction index \> 40.
- Patients with moderate to severe lower urinary tract symptoms (LUTS) according to the International Prostate Symptom Score (IPSS). Score between 8...
- Patients with a prostate volume between 40 and 80 cc, measured by urological ultrasound or MRI.
You likely can't join if
- History of prior prostatic obstructive or urethral surgery.
- Diagnosis of prostate neoplasia.
- Diagnosis of urothelial neoplasia.
- Lack of flowmetry or IPSS data before surgery.
- Diagnosis or suspicion of hypo/acontractile detrusor before prostatic obstructive surgery.
- Diagnosis or suspicion of neurogenic bladder or neurological disease.
See the full eligibility criteria
- Patients with maximum flow rate \ 15 ml/sec and urodynamic study showing high-flow obstruction defined as bladder outlet obstruction index \> 40.
- Patients with moderate to severe lower urinary tract symptoms (LUTS) according to the International Prostate Symptom Score (IPSS). Score between 8 and 35.
- Patients with a prostate volume between 40 and 80 cc, measured by urological ultrasound or MRI.
- History of prior prostatic obstructive or urethral surgery.
- Diagnosis of prostate neoplasia.
- Diagnosis of urothelial neoplasia.
- Lack of flowmetry or IPSS data before surgery.
- Diagnosis or suspicion of hypo/acontractile detrusor before prostatic obstructive surgery.
- Diagnosis or suspicion of neurogenic bladder or neurological disease.
- History of pelvic radiation therapy.
The study team makes the final eligibility decision.
Where it's taking place
- Santiago de Compostela, A Coruña, Spain
- Barcelona, BARCELONA, Spain
- L'Hospitalet de Llobregat, BARCELONA, Spain
- Santander, Cantabria, Spain
- Gijón, Principality of Asturias, Spain
- Valladolid, Valladolid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago de Compostela, A Coruña, Spain; Barcelona, BARCELONA, Spain; L'Hospitalet de Llobregat, BARCELONA, Spain; Santander, Cantabria, Spain; Gijón, Principality of Asturias, Spain; Valladolid, Valladolid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.